Qube Research & Technologies LTD Iovance Biotherapeutics, Inc. Transaction History

Qube Research & Technologies LTD

$62.3 Billion
Q2 2024

A detailed history of Qube Research & Technologies LTD transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 200,401 shares of IOVA stock, worth $2.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

200,401

Previous 55,010 264.3%

Holding current value

$2.07 Million

Previous $815,000 97.18%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$7.78 - $14.19 $1.13 Million - $2.06 Million	145,391 Added 264.3%	200,401 $1.61 Million
Q1 2024 May 14, 2024	BUY	$7.59 - $17.47 $417,525 - $961,024	55,010 New	55,010 $815,000
Q3 2023 Nov 13, 2023	SELL	$4.44 - $8.79 $527,378 - $1.04 Million	-118,779 Reduced 92.01%	10,318 $46,000
Q2 2023 Aug 14, 2023	BUY	$5.36 - $9.06 $166,513 - $281,457	31,066 Added 31.69%	129,097 $908,000
Q1 2023 May 15, 2023	SELL	$5.53 - $8.22 $486,219 - $722,735	-87,924 Reduced 47.28%	98,031 $598,000
Q4 2022 Feb 14, 2023	BUY	$5.62 - $10.0 $1.05 Million - $1.86 Million	185,955 New	185,955 $1.19 Million
Q1 2021 May 14, 2021	SELL	$28.67 - $52.59 $162,042 - $297,238	-5,652 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$28.04 - $50.26 $166,389 - $298,242	-5,934 Reduced 51.22%	5,652 $262,000
Q3 2020 Nov 12, 2020	SELL	$27.75 - $36.3 $1.33 Million - $1.73 Million	-47,753 Reduced 80.47%	11,586 $381,000
Q2 2020 Aug 14, 2020	BUY	$27.21 - $41.0 $1.61 Million - $2.43 Million	59,339 New	59,339 $1.63 Million
Q1 2020 May 15, 2020	SELL	$19.54 - $38.85 $791,799 - $1.57 Million	-40,522 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$17.95 - $29.41 $727,369 - $1.19 Million	40,522 New	40,522 $1.12 Million

Others Institutions Holding IOVA

# of Institutions

323

Shares Held

239M

Call Options Held

1.27M

Put Options Held

1.68M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.63B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Iovance Biotherapeutics, Inc. Transaction History